In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...